search
Back to results

Helping Hypertensive Latinos to Improve Medication Adherence

Primary Purpose

Hypertension

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Adherence Intervention
Usual Care
Sponsored by
NYU Langone Health
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Hypertension focused on measuring Latino

Eligibility Criteria

18 Years - 100 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Have uncontrolled hypertension defined as BP>140/90 mmHg on at least two consecutive visits in the past year (or BP>130/80 mmHg for those with diabetes or kidney disease)
  • Framingham Risk Scores (FRS) >20% (or at least one CVD risk factor including hyperlipidemia or diabetes)
  • Be taking at least one antihypertensive medication;
  • Self-identify as Latino

Exclusion Criteria:

  • Refuse or are unable to provide informed consent;
  • Currently participate in another hypertension study;
  • Have significant psychiatric comorbidity

Sites / Locations

  • New York University School of Medicine

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

High Risk Latino Patients Adherence Intervention

High Risk Latinos Usual Care

Arm Description

74 high risk Latinos with uncontrolled hypertension

74 high risk Latinos with uncontrolled hypertension

Outcomes

Primary Outcome Measures

Rate of Medication Adherence assessed with electronic drug monitoring devices (EMD)
Adherence will be defined as the number of times the EMD records an opening of the pill bottle cap for each day the patient was in the study.

Secondary Outcome Measures

Self-reported medication adherence
Self-reported adherence will be measured with a validated tool. Adherence will be defined as the percent adherence between baseline and 6 months B. Blood pressure control
Blood pressure reduction
Difference between the baseline and systolic and diastolic BP readings at 6 months.
Blood pressure control
Rate of blood pressure control at 6 months

Full Information

First Posted
June 6, 2018
Last Updated
July 24, 2018
Sponsor
NYU Langone Health
search

1. Study Identification

Unique Protocol Identification Number
NCT03560596
Brief Title
Helping Hypertensive Latinos to Improve Medication Adherence
Official Title
Helping Hypertensive Latinos to Improve Medication Adherence
Study Type
Interventional

2. Study Status

Record Verification Date
July 2018
Overall Recruitment Status
Completed
Study Start Date
April 4, 2013 (Actual)
Primary Completion Date
June 4, 2016 (Actual)
Study Completion Date
August 1, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
NYU Langone Health

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Poor medication adherence is a major contributor to inadequate BP control, and is associated with 125,000 deaths annually. Translation of adherence interventions to community-based primary care practices where majority of Latino patients receive care is non-existent. Thus, the development of tailored interventions targeted at improving medication adherence in the Latino population is needed in order to address the racial disparities in BP control between Latinos and whites. This proposal provides a unique opportunity to address this gap in the literature. Using a randomized control design (RCT), the study will evaluate the effect of a culturally tailored, practice-based intervention on medication adherence in 148 high-risk Latino patients with uncontrolled HTN. To facilitate translation into routine practices, the intervention will be integrated into the clinic's electronic medical record (EMR) system, and will be delivered by trained, bilingual Health Coaches.
Detailed Description
Latinos are the fastest growing ethnic group of the U.S. with a growth rate of 43% compared to 23% among whites over the past decade. This increase is four times the nation's 9.7% growth rate, and accounts for more than half of the total U.S. population increase of 27.3 million during this period. This growth is accompanied by a significant increase in cardiovascular disease (CVD)-related morbidity and mortality. Despite increasing trends in the awareness and treatment of hypertension (HTN) among all groups, Latinos have the lowest blood pressure (BP) control rates in the U.S. Although barriers to optimal HTN control such as poor access, and low awareness have been used to explain the disparities in BP control between Latinos and whites, BP control rates remain lower among Latinos who receive treatment compared to whites. This enigma may be explained by the disproportionately poorer adherence to prescribed antihypertensive medications among Latinos compared to whites. Poor medication adherence is a major contributor to inadequate BP control, and is associated with 125,000 deaths annually. Despite over 30 years of research dedicated to understanding adherence behaviors in hypertensive patients, data in Latino patients is scant. More importantly, translation of adherence interventions to community-based primary care practices where majority of Latino patients receive care is non-existent.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
Keywords
Latino

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
Participant
Allocation
Randomized
Enrollment
119 (Actual)

8. Arms, Groups, and Interventions

Arm Title
High Risk Latino Patients Adherence Intervention
Arm Type
Experimental
Arm Description
74 high risk Latinos with uncontrolled hypertension
Arm Title
High Risk Latinos Usual Care
Arm Type
Active Comparator
Arm Description
74 high risk Latinos with uncontrolled hypertension
Intervention Type
Behavioral
Intervention Name(s)
Adherence Intervention
Intervention Description
9 sessions with bilingual health coaches who will utilize a culturally tailored adherence checklist to identify patients specific medication adherence barriers.
Intervention Type
Behavioral
Intervention Name(s)
Usual Care
Intervention Description
standard hypertension treatment recommendations as determined by PCP
Primary Outcome Measure Information:
Title
Rate of Medication Adherence assessed with electronic drug monitoring devices (EMD)
Description
Adherence will be defined as the number of times the EMD records an opening of the pill bottle cap for each day the patient was in the study.
Time Frame
6 Months
Secondary Outcome Measure Information:
Title
Self-reported medication adherence
Description
Self-reported adherence will be measured with a validated tool. Adherence will be defined as the percent adherence between baseline and 6 months B. Blood pressure control
Time Frame
6 Months
Title
Blood pressure reduction
Description
Difference between the baseline and systolic and diastolic BP readings at 6 months.
Time Frame
6 Months
Title
Blood pressure control
Description
Rate of blood pressure control at 6 months
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Have uncontrolled hypertension defined as BP>140/90 mmHg on at least two consecutive visits in the past year (or BP>130/80 mmHg for those with diabetes or kidney disease) Framingham Risk Scores (FRS) >20% (or at least one CVD risk factor including hyperlipidemia or diabetes) Be taking at least one antihypertensive medication; Self-identify as Latino Exclusion Criteria: Refuse or are unable to provide informed consent; Currently participate in another hypertension study; Have significant psychiatric comorbidity
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Antoinette Schoenthaler
Organizational Affiliation
NYU Langone Health
Official's Role
Principal Investigator
Facility Information:
Facility Name
New York University School of Medicine
City
New York
State/Province
New York
ZIP/Postal Code
10016
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
31625041
Citation
Schoenthaler A, de la Calle F, Pitaro M, Lum A, Chaplin W, Mogavero J, Rosal MC. A Systems-Level Approach to Improving Medication Adherence in Hypertensive Latinos: a Randomized Control Trial. J Gen Intern Med. 2020 Jan;35(1):182-189. doi: 10.1007/s11606-019-05419-3. Epub 2019 Oct 17.
Results Reference
derived

Learn more about this trial

Helping Hypertensive Latinos to Improve Medication Adherence

We'll reach out to this number within 24 hrs